PharmiWeb.com - Global Pharma News & Resources

Reports - Press Releases

Date Title Company
09-May-2025 CV Sciences, Inc. to Announce First Quarter 2025 Results on May 14, 2025 ACCESS Newswire
09-May-2025 Akero Therapeutics Announces Publication of Phase 2b SYMMETRY Trial in the New England Journal of Medicine Akero Therapeutics
09-May-2025 uniQure Announces First Quarter 2025 Financial Results and Highlights of Recent Company Progress uniQure
09-May-2025 Faith Bose Joins Health Net Connections LTD as UK Sales Director Health Net Connections Ltd
09-May-2025 Theriva Biologics Announces Closing of $7.5 Million Public Offering Theriva Biologics
09-May-2025 Genmab Announces Financial Results for the First Quarter of 2024 Genmab
09-May-2025 ProQR Announces First Quarter 2025 Operating and Financial Results ProQR
09-May-2025 Acquisition Bolsters Aspire’s Strategic Portfolio Aspire Pharma Limited
09-May-2025 Kelso Pharma builds for future growth with appointment of life sciences leader as Chief Operating Officer Kelso Pharma
09-May-2025 Life sciences growth requires payment rates to return to internationally comparable levels ABPI
09-May-2025 ABPI comment on UK-US trade agreement Association of the British Pharmaceutical Industry (ABPI)
09-May-2025 Akero Therapeutics Presents Week 96 Results from Phase 2b SYMMETRY Clinical Trial of Efruxifermin in Patients with Compensated Cirrhosis Caused by MASH Showing Fibrosis Improvement without Worsening of MASH at the EASL Congress 2025 Akero Therapeutics
09-May-2025 New Survey Reveals Enterprise AI Breakthroughs Advancing, But Business Impact Still Out of Reach Domino Data Lab
09-May-2025 NextCell CSO Lindsay Davies Honoured with Multiple New Leadership Roles Within European Cell Therapy Community NextCell Pharma AB
09-May-2025 Jabez Biosciences, Inc. Announced Phase 1 Clinical Trial of JBZ-001 at AACR 2025 ACCESS Newswire
09-May-2025 WellBridge Surgical Recognized with IBJ Fast 25 Award, Capping a Year of Prestigious Honors ACCESS Newswire
09-May-2025 Alligator Bioscience Announces that 85% of the Warrant Programme TO 12 has Been Secured and that the Outstanding Loan has Been Renegotiated ACCESS Newswire
09-May-2025 EDGe Surgical Raises Over $1.3M to Accelerate Commercial Expansion and Launch New Ortho EDG SKUs ACCESS Newswire
09-May-2025 Black Book Research Unveils Strategic Innovations to Lead Healthcare IT Market Intelligence in the Age of AI ACCESS Newswire
09-May-2025 Zomedica to Report First Quarter 2025 Financial Results with a Business Update on Thursday, May 15, 2025 at 4:30 pm ET ACCESS Newswire